RESUMO
ABSTRACT: While pediatric human immunodeficiency virus (HIV) testing has been more focused on children below 18âmonths through prevention of mother to child transmission of HIV (PMTCT), the yield of this approach remains unclear comparatively to testing children above 18âmonths through routine provider-initiated testing and counselling (PITC). This study aimed at assessing and comparing the HIV case detection and antiretroviral therapy (ART) enrolment among children below and above 18âmonths of age in Cameroon. This information is required to guide the investments in HIV testing among children and adolescents.We conducted a cross-sectional study where we invited parents visiting or receiving HIV care in 3 hospitals to have their children tested for HIV. HIV testing was done using polymerase chain reaction (PCR) and antibody rapid tests for children <18âmonths and those ≥18âmonths, respectively. We compared HIV case detection and ART initiation between the 2 subgroups of children and this using Chi-square test at 5% significant level.A total of 4079 children aged 6 weeks to 15âyears were included in the analysis. Compared with children <18âmonths, children group ≥18âmonths was 4-fold higher among those who enrolled in the study (80.3% vs 19.7%, Pâ<â.001); 3.5-fold higher among those who tested for HIV (77.6% vs 22.4%, Pâ<â.001); 6-fold higher among those who tested HIV+ (85.7% vs 14.3%, Pâ=â.24), and 11-fold higher among those who enrolled on ART (91.7% vs 8.3%, Pâ=â.02).Our results show that 4 out of 5 children who tested HIV+ and over 90% of ART enrolled cases were children ≥18âmonths. Thus, while rolling out PCR HIV testing technology for neonates and infants, committing adequate and proportionate resources in antibody rapid testing for older children is a sine quo none condition to achieve an acquired immunodeficiency syndrome (AIDS)-free generation.